Compresso Ibu 85 Par
Generic Name: compresso ibu 85 par
Dosage form: POWDER. Active ingredients: IBUPROFEN (85 mg/100mg). Category: DRUG FOR FURTHER PROCESSING.
Overview
Dosage form: POWDER. Active ingredients: IBUPROFEN (85 mg/100mg). Category: DRUG FOR FURTHER PROCESSING.
Dosage
Available as powder.
Related Medications
Amino Acid Mixture Blend F
amino acid mixture blend f
Dosage form: POWDER. Active ingredients: ALANINE (8.5 kg/100kg); ARGININE (9.55 kg/100kg); GLYCINE (4.56 kg/100kg); HISTIDINE (6.4 kg/100kg); ISOLEUCINE (7.6 kg/100kg); LEUCINE (9.1 kg/100kg); LYSINE HYDROCHLORIDE (8.5 kg/100kg); METHIONINE (7.6 kg/100kg); PHENYLALANINE (5.1 kg/100kg); PROLINE (5.3 kg/100kg); SERINE (4.56 kg/100kg); THREONINE (5.75 kg/100kg); TRYPTOPHAN (2.42 kg/100kg); TYROSINE (2.69 kg/100kg); VALINE (12.45 kg/100kg). Category: DRUG FOR FURTHER PROCESSING.
Asenapine Maleate
asenapine maleate
11 DESCRIPTION SAPHRIS contains asenapine maleate which is an atypical antipsychotic that is available for sublingual administration. Asenapine belongs to the class dibenzo-oxepino pyrroles. The chemical designation is (3a RS ,12b RS )-5-Chloro-2-methyl-2,3,3a,12b-tetrahydro-1 H dibenzo[2,3:6,7]oxepino[4,5- c ]pyrrole (2 Z )-2-butenedioate (1:1). Its molecular formula is C 17 H 16 ClNO•C 4 H 4 O 4 and its molecular weight is 401.84 (free base: 285.8).
Mirikizumab-mrkz
mirikizumab-mrkz
Interleukin-23 Antagonist [EPC]
11 DESCRIPTION Mirikizumab-mrkz is a humanized immunoglobulin G4 (IgG4) variant monoclonal antibody that is directed against the p19 subunit of IL-23 and does not bind IL-12. Mirikizumab-mrkz is produced in Chinese Hamster Ovary (CHO) cells by recombinant DNA technology and it is composed of two identical light chain polypeptides and two identical heavy chain polypeptides with an overall molecular weight of approximately 147 kDa.
Medical Disclaimer
This drug information is for educational purposes only and should not replace professional medical advice. Drug information is sourced from the FDA National Drug Code Directory and Structured Product Labeling. Always consult with a healthcare provider before starting, stopping, or changing any medication.